Simtra BioPharma Solutions, a global contract development and manufacturing (CDMO) specializing in injectable medicines, has purchased a 65-acre property (301 N. Curry Pike) with more than 300,000 square feet of available space for expansion under-roof near its existing manufacturing facility in Bloomington, Indiana. The addition of this site provides Simtra with significant flexibility to rapidly expand its manufacturing footprint in the United States to respond to growing capacity demands f...